Answers are grounded in this paper and cite their sources.
cumulative dose (hazard ratio, 0·119; P < 0·0001). Less frequent bortezomib dosing results in comparable efficacy, and a higher cumulative dose than the originally approved bortezomib dosing schedule, which may be in part be due to reduced toxicity and fewer dose reductions/interruptions.
No takes yet. Share an insight, caveat, or question.
Parasrampuria et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: